Part D Overhaul: The Silver Lining Amid Very Dark Cloud Of US Drug Pricing Bill
Senate version of a potential drug pricing overhaul in the US includes one silver lining for manufacturers: a re-design and update of the Part D drug benefit. Is there any chance of extracting that item for the very dark clouds around it?